Joel Claveau

Lagacé F, Noorah BN, Conte S, Mija LA, Chang J, Cattelan L, LeBeau J, Claveau J, Turchin I, Gulliver W, Gniadecki R, Netchiporouk E, Miller WH, Salopek TG, Rahme E, Peláez S, Litvinov IV

Assessing Skin Cancer Risk Factors, Sun Safety Behaviors and Melanoma Concern in Atlantic Canada: A Comprehensive Survey Study

Cancers (Basel), 15 (15), 2023.

Résumé | Liens:

Paquette C, Careau AM, Bergeron J, Carpentier C, Claveau J

A case of eruptive xanthomas associated with pregnancy unmasking a G188E heterozygous mutation of the lipoprotein lipase gene: A case report

SAGE Open Med Case Rep, 10 , 2022.

Résumé | Liens:

Berman-Rosa M, Logan J, Ghazawi FM, Le M, Conte S, Netchiporouk E, Mukovozov IM, Cyr J, Mourad A, Miller WH, Claveau J, Salopek TG, Gniadecki R, Sasseville D, Rahme E, Lagacé F, Litvinov IV

Analysis of Geographic and Environmental Factors and Their Association with Cutaneous Melanoma Incidence in Canada

Dermatology, 238 (6), 2022.

Résumé | Liens:

Conte S, Ghazawi FM, Le M, Nedjar H, Alakel A, Lagacé F, Mukovozov IM, Cyr J, Mourad A, Miller WH, Claveau J, Salopek TG, Netchiporouk E, Gniadecki R, Sasseville D, Rahme E, Litvinov IV

Population-Based Study Detailing Cutaneous Melanoma Incidence and Mortality Trends in Canada

Front Med (Lausanne), 9 , 2022.

Résumé | Liens:

Zhou S, Sivachandran S, Sikorski D, Xu HH, Lagacé F, Claveau J, Salopek TG, Gniadecki R, Litvinov IV

Reflex Molecular Testing in Melanoma Diagnosis: When Should BRAF Mutation Testing Be Ordered and Who Should Order It?

J Cutan Med Surg, 26 (2), 2022.

| Liens:

Thawer A, Miller WH, Gregorio N, Claveau J, Rajagopal S, Savage KJ, Song X, Petrella TM, On Behalf Of The Canadian Working Group

Management of Pyrexia Associated with the Combination of Dabrafenib and Trametinib: Canadian Consensus Statements

Curr Oncol, 28 (5), 2021.

Résumé | Liens:

Zhou S, Sikorski D, Xu H, Zubarev A, Chergui M, Lagacé F, Miller WH, Redpath M, Ghazal S, Butler MO, Petrella TM, Claveau J, Nessim C, Salopek TG, Gniadecki R, Litvinov IV

Defining the Criteria for Reflex Testing for BRAF Mutations in Cutaneous Melanoma Patients

Cancers (Basel), 13 (9), 2021.

Résumé | Liens:

Laurin C, Claveau J, Trahan S, Gagnon LP, Kalavrouziotis D, Perron J

Asymptomatic Left Ventricular Malignant Psammomatous Melanotic Schwannoma

CJC Open, 3 (7), 2021.

Résumé | Liens:

Slingluff CL, Lewis KD, Andtbacka R, Hyngstrom J, Milhem M, Markovic SN, Bowles T, Hamid O, Hernandez-Aya L, Claveau J, Jang S, Philips P, Holtan SG, Shaheen MF, Curti B, Schmidt W, Butler MO, Paramo J, Lutzky J, Padmanabhan A, Thomas S, Milton D, Pecora A, Sato T, Hsueh E, Badarinath S, Keech J, Kalmadi S, Kumar P, Weber R, Levine E, Berger A, Bar A, Beck JT, Travers JB, Mihalcioiu C, Gastman B, Beitsch P, Rapisuwon S, Glaspy J, McCarron EC, Gupta V, Behl D, Blumenstein B, Peterkin JJ

Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence

J Immunother Cancer, 9 (10), 2021.

Résumé | Liens:

Derstenfeld A, Shear NH, Mereniuk A, Claveau J, McCuaig C, Litvinov IV

The Need to Evaluate the Risks and Benefits Posed by Quebec Bill 43 Expanding Nurse Practitioners' Scope of Practice

J Cutan Med Surg, 24 (4), 2020.

| Liens: